HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jianguo Sun Selected Research

Jianguo Sun Research Topics

Disease

33Neoplasms (Cancer)
05/2022 - 12/2007
20Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 12/2015
12Lung Neoplasms (Lung Cancer)
01/2022 - 12/2007
7Breast Neoplasms (Breast Cancer)
01/2021 - 01/2012
7Hepatocellular Carcinoma (Hepatoma)
12/2017 - 04/2011
6Glaucoma
12/2022 - 09/2016
5Prostatic Neoplasms (Prostate Cancer)
12/2021 - 09/2011
5Neoplasm Metastasis (Metastasis)
01/2019 - 09/2011
3Carcinoma (Carcinomatosis)
07/2017 - 01/2012
2COVID-19
09/2021 - 08/2021
2Brain Neoplasms (Brain Tumor)
01/2021 - 01/2021
2Pain (Aches)
01/2021 - 01/2021
2Carcinogenesis
10/2020 - 01/2015
2Disease Progression
01/2019 - 04/2016
2Type 2 Diabetes Mellitus (MODY)
12/2017 - 12/2015
2Blindness (Hysterical Blindness)
10/2017 - 05/2015
2Cicatrix (Scar)
08/2017 - 01/2017
2Phlebitis
08/2016 - 04/2016
2Leukemia
08/2016 - 07/2013
2Lymphatic Metastasis
03/2016 - 04/2013
2Reperfusion Injury
01/2016 - 03/2014
2Osteoporosis
10/2013 - 01/2013
2Glioma (Gliomas)
10/2013 - 10/2012
1Radiation Pneumonitis
03/2022
1Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2022
1Adenocarcinoma of Lung
02/2022
1Uveitis
01/2022
1Wounds and Injuries (Trauma)
01/2022
1Ganglion Cysts (Ganglion)
01/2022
1Nasopharyngeal Carcinoma
10/2021
1Stomatitis
10/2021
1Inflammation (Inflammations)
09/2021
1Corneal Neovascularization
09/2021

Drug/Important Bio-Agent (IBA)

11Pharmaceutical PreparationsIBA
02/2021 - 01/2012
8Tyrosine Kinase InhibitorsIBA
02/2022 - 05/2016
7Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2013
6ErbB Receptors (EGF Receptor)IBA
02/2022 - 05/2016
6Immune Checkpoint InhibitorsIBA
09/2021 - 01/2018
6Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2012
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2021 - 09/2011
4Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2021 - 09/2016
4Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021 - 05/2016
4Gefitinib (Iressa)FDA Link
12/2019 - 05/2016
3proxalutamideIBA
12/2021 - 10/2020
3Arachidonic Acid (Vitamin F)IBA
01/2021 - 10/2013
3Messenger RNA (mRNA)IBA
01/2021 - 03/2017
3MicroRNAs (MicroRNA)IBA
10/2020 - 07/2013
3Radiation-Sensitizing AgentsIBA
01/2018 - 10/2012
3asulacrineIBA
12/2016 - 04/2016
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2012 - 12/2007
2Brimonidine Tartrate (Alphagan)FDA LinkGeneric
12/2022 - 03/2017
2EndostatinsIBA
03/2022 - 02/2012
2PlatinumIBA
02/2022 - 04/2016
2Nerve Growth Factors (Neurotrophins)IBA
01/2022 - 12/2017
2Androgen Receptors (Androgen Receptor)IBA
12/2021 - 10/2020
2Silicon Dioxide (Silica)FDA LinkGeneric
09/2021 - 12/2018
2pembrolizumabIBA
01/2021 - 01/2019
2Biological ProductsIBA
10/2020 - 01/2019
2Circulating Tumor DNAIBA
05/2020 - 01/2019
2B7-H1 AntigenIBA
01/2020 - 01/2018
2SolutionsIBA
12/2019 - 08/2017
2Metformin (Glucophage)FDA LinkGeneric
12/2019 - 12/2015
2Peptides (Polypeptides)IBA
01/2019 - 09/2007
2Cadherins (E-Cadherin)IBA
01/2019 - 01/2019
2Indicators and Reagents (Reagents)IBA
01/2018 - 01/2018
2Cisplatin (Platino)FDA LinkGeneric
12/2017 - 12/2007
2Amsacrine (AMSA)IBA
12/2016 - 08/2016
2AcidsIBA
01/2016 - 01/2007
2Plant Preparations (Preparation, Plant)IBA
01/2016 - 08/2009
2Neuroprotective AgentsIBA
03/2014 - 04/2012
2CpG ODN107IBA
10/2013 - 10/2012
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2012 - 12/2010
1Therapeutic UsesIBA
12/2022
1Silicone Elastomers (SE 30)IBA
12/2022
1Ophthalmic Solutions (Eye Drops)IBA
12/2022
1endostar proteinIBA
03/2022
1icotinibIBA
02/2022
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2022
1Retinaldehyde (Retinal)IBA
01/2022
1NLR ProteinsIBA
01/2022
1Long Noncoding RNAIBA
01/2022
1CollagenIBA
01/2022
1Anaplastic Lymphoma KinaseIBA
12/2021
1Contrast MediaIBA
11/2021
1LipidsIBA
10/2021
1Bevacizumab (Avastin)FDA Link
09/2021
1TamoxifenFDA LinkGeneric
01/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2021
1ThymosinIBA
01/2021

Therapy/Procedure

15Radiotherapy
05/2022 - 10/2012
12Therapeutics
01/2021 - 01/2012
8Drug Therapy (Chemotherapy)
02/2022 - 12/2007
3Immunotherapy
01/2021 - 05/2019
2Filtering Surgery
08/2017 - 01/2017
1Cell Transplantation
01/2022
1Keratectomy
01/2022
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2021
1Massage (Zone Therapy)
10/2021
1Contraindications
09/2021
1Critical Care (Surgical Intensive Care)
08/2021